The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to three scientists – Karl Deisseroth, Peter Hegemann ...

Isao Teshirogi, Shionogi's chief executive. Shionogi has reached a $2 billion agreement to buy Anglo-US biotech IntraBio and ...

Marcus Evans will host the PharmaMarketing Summit from 21 to 22 January 2027 at the prestigious Four Seasons Hotel Westlake ...

If it reaches the market, profits on lixudebart sales will be shared 55% to CSL and 45% to Alentis. Under the terms of the ...

The much-anticipated pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs has arrived, with a deal that spans the current injectable products as well as ...

UK healthcare authorities have approved a free messaging app for use in hospitals, in a move designed to stop staff sharing sensitive clinical information using consumer services such as WhatsApp.

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially. The French pharma group confirmed this ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a deal to buy Thirty Madison in an all-stock deal valued at around $500 million. Short Hills, New ...

Sanofi has said it will press ahead with regulatory filings for atopic dermatitis (AD) candidate amlitelimab after reporting positive data in two more phase 3 trials. The company said that the results ...

Zealand Pharma's CEO, Adam Steensberg. Shares in Zealand Pharma lost around a third of their value today, after it reported phase 2 data with Roche-partnered weight-loss therapy petrelintide. The sell ...

Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now expected to be down around $9 ...